Immune dysfunction in endotoxicosis: Role of nitric oxide produced by inducible nitric oxide synthase

Critical Care Medicine

Volumn 33, Issue 4, 2005, Pages 716-720

  Miki, Shigeki ^a   Takeyama, Naoshi ^b   Tanaka, Takaya ^a   Nakatani, Toshio ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KANSAI ELECTRIC POWER CO   (Japan)

Author keywords

Immunoparalysis; Inducible nitric oxide synthase; Lipopolysaccharide; Splenocyte; T helper 1

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENDOTOXEMIA; FLOW CYTOMETRY; IMMUNOPATHOLOGY; KNOCKOUT MOUSE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SURVIVAL RATE; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSPECTIVE STUDIES; REFERENCE VALUES; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TH1 CELLS; TH2 CELLS;

EID: 17044426416     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000159200.69314.3A     Document Type: Article

References (37)

1. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24:1125-1128
2. Kelly JL, O'Suilleabhain CB, Soberg CC, et al: Severe injury triggers antigen-specific T-helper cell dysfunction. Shock 1999; 12:39-45
3. Allen ML, Peters MJ, Goldman A, et al: Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 2002; 30:1140-1145
4. Hensler T, Hecker H, Heeg K, et al: Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 1997; 65:2283-2291
5. Zedler S, Bone RC, Baue AE, et al: T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med 1999; 27:66-72
6. Reddy RC, Chen GH, Tekchandani PK, et al: Sepsis-induced immunosuppression: From bad to worse. Immunol Res 2001; 24:273-287
7. O'Sullivan ST, Lederer JA, Horgan AF, et al: Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222:482-492
8. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001; 163:316-321
9. Castro A, Bemer V, Nobrega A, et al: Administration to mice of endotoxin from gram-negative bacteria leads to activation and apoptosis of T lymphocytes. Eur J Immunol 1998; 28:488-495
10. Schmidt HHHW, Walter U: NO at work. Cell 1994; 78:919-925
11. van der Veen RC: Nitric oxide and T helper cell immunity. Int Immunopharmacol 2001; 1:1491-1500
12. van der Veen RC, Dietlin TA, Pen L, et al: Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretion. Cell Immunol 1999; 193:194-201
13. Huang FP, Niedbala W, Wei XQ, et al: Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol 1998; 28:4062-4070
14. Mosmann TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-146
15. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996; 383:787-793
16. Meldrum DR, Ayala A, Wang P, et al: Association between decreased splenic ATP levels and immunodepression: Amelioration with ATP-MgCl2. Am J Physiol 1991; 261:R351-357
17. Waldrop SL, Pitcher CJ, Peterson DM, et al: Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry. J Clin Invest 1997; 99:1739-1750
18. Akahori M, Yamada S, Takeyama N, et al: Nitric oxide ameliorates actinomycin D/endotoxin-induced apoptosis of L929 cells is prevented by nitric oxide. J Surg Res 1999; 85:286-293
19. Faist E, MewesA, Strasser T et al: Alteration of monocyte function following major injury. Arch Surg 1988; 123:287-292
20. Brune IK, Wilke W, Hensler T, et al: Down-regulation of T helper type I immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery. Am J Surg 1999; 177:55-60
21. Weighardt H, Heidecke CD, Emmanuilidis K, et al: Sepsis after major visceral surgery is associated with sustained and interferon-gamma-resistant defects of monocyte cytokine production. Surgery 2000; 127:309-315
22. Napolitano LM, Campbell C, Bass BL, et al: Kinetics of splenocyte interleukin-4 production after injury and lethal endotoxin challenge. J Surg Res 1997; 67:33-39
23. Napolitano LM, Campbell C: Polymicrobial sepsis following trauma inhibits interleukin-10 secretion and lymphocyte proliferation. J Trauma 1995; 39:104-111
24. Mack VE, McCarter MD, Naama HA, et al: Dominance of T-helper 2-type cytokines after severe injury. Arch Surg 1996; 131:1303-1309
25. Wahl SM, Costa GL, Corcoran M, et al: Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol 1993; 150:3553-3560
26. Ayala A, Chung CS, Song GY, et al: IL-10 mediation of activation-induced Th1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis. Cytokine 2001; 14:37-48
27. van der Pouw Kraan TC, Boeije LC, Smeenk RJ, et al: Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 1995; 181:775-779
28. Kopf M, Baumann H, Freer G, et al: Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368:339-342
29. Bogdan C: The multiplex function of nitric oxide in (auto)immunity. J Exp Med 1998; 187:1361-1365
30. Chung CS, Song GY, Wang W: Septic mucosal intraepithelial lymphoid immune suppression: Role of nitric oxide not interleukin-10 or transforming growth factor-β. J Trauma 2000; 48:807-813
31. Hollenberg SM, Broussard M, Osman J, et al: Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 2000; 86:774-779
32. Cobb JP, Hotchkiss RS, Swanson PE, et al: Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 1999; 126:438-442
33. Fenyk-Melody JE, Garrison AE, Brunnert SR, et al: Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J Immunol 1998; 160:2940-2946
34. Wei XQ, Charles IG, Smith A, et al: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375:408-411
35. Kox WJ, Volk T, Kox SN, et al: Immunomodulatory therapies in sepsis. Intensive Care Med 2000; 26:S124-S128
36. Munoz C, Carlet J, Fitting C, et al: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88:1747-1754
37. Ayala A, Chung CS, Grutkoski PS, et al: Mechanisms of immune resolution. Crit Care Med 2003; 31:S558-S571